Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
From Hallucinations to Multiorgan Failure: A Fulminant Presentation of Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0753; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Despite corticosteroids, rituximab, cyclophosphamide, and plasmapheresis, he developed refractory volume overload and escalating respiratory failure. Prognosis in fulminant multiorgan disease is poor despite maximal therapy. Early recognition, multidisciplinary intervention, and timely goals-of-care discussions are essential." 
Acute Respiratory Distress Syndrome • Alzheimer's Disease • ANCA Vasculitis • Cardiovascular • CNS Disorders • Cognitive Disorders • Dementia • Diabetes • Epilepsy • Glomerulonephritis • Hematological Disorders • Hypertension • Infectious Disease • Inflammation • Ischemic stroke • Lewy Body Disease • Lupus Nephritis • Metabolic Disorders • Nephrology • Pneumonia • Pulmonary Disease • Renal Disease • Respiratory Diseases • Type 2 Diabetes Mellitus • Vascular Neurology • Vasculitis • MPO
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559422
 
Hari Priya Sri Sai Mannam; Wan-Chi Chan; Salam Kadhem
 
Oct 2, 2026
 
Prev Next